General MedicationsINJECTIONStandard

ROPIVACAINE HYDROCHLORIDE

Standard Dose

5MG/ML(0.5%)

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Prescription

Summary

Approval overview ROPIVACAINE HYDROCHLORIDE is listed in Drugs@FDA under application 078601 (ANDA).

Marketing status: Prescription Active ingredient ROPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE; INJECTION - 5MG/ML(0.5%) Sponsor NAVINTA LLC Submission history Latest submission status date: 2014-07-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview ROPIVACAINE HYDROCHLORIDE is listed in Drugs@FDA under application 078601 (ANDA). Marketing status: Prescription Active ingredient ROPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE; INJECTION - 5MG/ML(0.5%) Sponsor NAVINTA LLC Submission history Latest submission status date: 2014-07-17 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription

Interaction Notes

No interaction notes stored yet.